During the COVID-19 pandemic, healthcare professionals looking after myeloma patients face important and difficult decisions about the best way to treat their patients, whilst minimising their risk of infection. Several myeloma specialists have been sharing their experience as they work together to consider the safest and most effective ways to manage this vulnerable group of patients. Here we have compiled a short list of informative webinars, podcasts and articles to keep…Details
Myeloma UK have developed an information hub to help keep patients up to date with the latest news on COVID-19. The COVID-19 Information Hub is a one stop shop for information about the COVID-19 pandemic and how it is affecting patients’ treatment and care. The Hub is being regularly updated with the latest news and guidance from the UK Government…Details
The response to the COVID-19 pandemic has put the UK Government and NHS on an emergency footing. With this substantial change to NHS services, there has been a rapid growth in published guidelines and policy to help Healthcare Professionals (HCPs) ensure patients get the right treatment and care. Here we have detailed some key sources…Details
The 61st American Society of Hematology Annual Meeting (ASH) took place on 7-10 December in Orlando, Florida. It was attended by over 30,000 scientists and clinicians from around the world and covered around 6,000 topics with over 700 myeloma abstracts. Here are some of our highlights from this year’s meeting. Myeloma XI There were five…Details
We have co-partnered education events for GPs with a number of Clinical Commissioning Groups across the UK.
Please get in touch if you can direct us to the relevant person in your local CCG or if you would be interested in hosting a GP education event at your hospital. Email firstname.lastname@example.orgDetails
We have collaborated with Macmillan to produce a Myeloma 10 top tips factsheet to support myeloma diagnosis by raising GP awareness. This includes guidance on when to suspect myeloma and which blood tests should be requested. The factsheet has been reviewed by expert haematologists and Macmillan GP Advisors to ensure the content is accurate from the perspective of both primary and secondary care clinicians.Details
Early diagnosis for myeloma patients is associated with improved overall survival. The one year survival rate for patients diagnosed via GP referral is significantly higher than those diagnosed following emergency admission (88% vs 62%). Fundamental to timely diagnosis of rarer cancers such as myeloma is increased GP awareness.Details
Pathologists and pathology labs play a critical role in diagnosis and the ongoing monitoring of myeloma patients. Like many areas of the NHS, they have been under increasing pressure to provide a consistent, high standard service over the years. To help alleviate some of the pressure in pathology services and provide good practice recommendations that…Details
This NICE guideline provides recommendations for non-specialists for the identification and referral guidance for children and adults who present with symptoms or risk factors of acute kidney injury.